Seoul, South Korea

Soo Young Kwak


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Soo Young Kwak in Hormone Formulation

Introduction

Soo Young Kwak is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biopharmaceuticals, particularly in hormone formulations. His innovative work focuses on enhancing the efficacy and stability of human follicle-stimulating hormone (FSH).

Latest Patents

Soo Young Kwak holds a patent for a "Long-acting human follicle-stimulating hormone formulation using immunoglobulin fragment." This invention relates to a long-acting human follicle-stimulating hormone formulation that has improved in vivo duration and stability. The formulation comprises a human follicle-stimulating hormone conjugate, which is prepared by covalently linking human follicle-stimulating hormone with an immunoglobulin Fc region via a non-peptidyl polymer. The long-acting formulation maintains the in vivo activity of human follicle-stimulating hormone at a relatively high level and remarkably increases its serum half-life. He has 1 patent to his name.

Career Highlights

Soo Young Kwak is associated with Hanmi Science Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in the development of innovative therapeutic solutions in the field of reproductive health.

Collaborations

He has collaborated with notable colleagues, including Chang Hwan Kim and Sung Kap Hong, to further enhance the impact of his research and innovations.

Conclusion

Soo Young Kwak's contributions to the field of hormone formulations exemplify the importance of innovation in biopharmaceuticals. His work not only advances scientific knowledge but also has the potential to improve patient outcomes in reproductive health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…